FOLD Q1 2018 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$17M+300.5% YoY

Gross Profit

$14M84.3% margin

Operating Income

-$56M-336.5% margin

Net Income

-$50M-299.0% margin

EPS (Diluted)

$-0.28

QoQ Revenue Growth

+13.4%

Cash Flow

Operating Cash Flow

-$50M

Free Cash Flow

-$50M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$870M

Total Liabilities

$348M

Stockholders' Equity

$522M

Cash & Equivalents

$114M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$4M	+300.5%
Gross Profit	$14M	$3M	+314.9%
Operating Income	-$56M	-$52M	-8.0%
Net Income	-$50M	-$55M	+9.2%